Home > Healthcare > Pharmaceuticals > Pharma Manufacturing > Biologics Outsourcing Market

Biologics Outsourcing Market Trends

Report ID: GMI6621
Published Date: Sep 2023
Report Format: PDF

Download Free Sample

Biologics Outsourcing Market Trends

The growing complexity of biologics has significantly increased outsourcing services in the biologics industry. Biologics, which include vaccines, therapeutic proteins, and monoclonal antibodies, are highly intricate and require specialized expertise and advanced technologies for their development, manufacturing, and quality control. The complexity arises from factors such as the use of living cells or organisms, intricate purification processes, and the need for stringent regulatory compliance.

As a result, biopharmaceutical companies are increasingly relying on outsourcing partners with the necessary expertise and infrastructure to navigate the complexities of biologics development and production. For instance, in February 2021, Affibody AB, a company focused on developing next-generation biopharmaceuticals partnered with Biovian Oy, a CDMO, for ABY-062 recombinant protein for clinical trial.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Biologics outsourcing market size was valued at USD 20.5 billion in 2022 and will reach USD 75 billion by 2032 due to the growing pipeline of biologic drugs, particularly in the fields of oncology, autoimmune disorders, and infectious diseases worldwide.

The antibodies product segment recorded 60.9% share in the industry in 2022 and will witness significant growth from 2023-2032 on account of rising application in the treatment of cancer, autoimmune diseases, and infectious diseases.

North America held 46.3% share in the industry in 2022 and is expected to register 12.2% CAGR from 2023-2032 owing to the robust healthcare infrastructure and the strong emphasis on innovations in the region.

AbbVie Inc., Thermo Fisher Scientific, Inc., Boehringer Ingelheim, International GmbH, Merck & Co., Inc., Lonza Group AG, and Catalent Inc. are some of the major biologics outsourcing companies worldwide.